Insider Trading June 17, 2026 10:13 PM

Atomera CTO Robert Mears Executes Stock Transactions Under Pre-Arranged Plan

Executive activity coincides with recent corporate earnings and technology advancements in GaN-on-silicon RF development.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
ATOM

Atomera Inc (NASDAQ:ATOM) Chief Technology Officer Robert J. Mears reported a series of stock transactions on June 15, 2026, involving both sales and acquisitions of the company's common stock. The transactions were executed under a Rule 10b5-1 trading plan, a mechanism designed to facilitate trades in compliance with securities regulations. Following these activities, Mears maintains a direct holding of 272,715 shares, with an additional 2,666 shares held indirectly through his spouse. This executive activity occurs against the backdrop of Atomera's recent financial reporting and technological progress in its core semiconductor materials business.

Atomera CTO Robert Mears Executes Stock Transactions Under Pre-Arranged Plan
ATOM
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Chief Technology Officer Robert Mears executed a Rule 10b5-1 plan to sell 8,182 shares at $9.46 and acquire 10,000 shares at $7.65, leaving him with 272,715 direct shares.
  • Atomera reported Q1 2026 earnings that met EPS expectations with a non-GAAP net loss of $0.14, but revenue fell short of forecasts at $11,000 versus $100,000.
  • The company announced advancements in GaN-on-silicon RF technology, achieving a tenfold reduction in parasitic channel charge through Mears Silicon Technology.

Robert J. Mears, serving as the Chief Technology Officer for Atomera Inc (NASDAQ:ATOM), filed a disclosure on June 15, 2026, detailing recent movements in the company's equity. The filing outlines a dual transaction involving the sale and acquisition of Atomera common stock, both conducted under the framework of a Rule 10b5-1 trading plan. This structured approach is typically utilized by insiders to manage stock transactions in a manner that avoids potential conflicts of interest or allegations of insider trading.

According to the report, Mears sold 8,182 shares of Atomera common stock at a price of $9.46 per share, resulting in a total transaction value of $77,401. On the identical date, he also acquired 10,000 shares of the company's common stock for a total value of $76,500, purchased at $7.65 per share. These acquisitions were the result of exercising incentive stock options, which were also executed under the same Rule 10b5-1 plan. After accounting for these transactions, Mears's direct ownership stands at 272,715 shares. Furthermore, an additional 2,666 shares are held indirectly through his spouse, bringing the total family-related holdings to 275,381 shares.

The executive activity comes as Atomera's stock has experienced significant volatility, surging 270% over the past six months. Despite this recent appreciation, the shares currently trade slightly above InvestingPro's Fair Value estimate. The company remains in an unprofitable state, with a market capitalization of $341 million. Atomera is included in a broader coverage of over 1,400 US equities analyzed through comprehensive Pro Research Reports.

In related developments, Atomera Inc reported its first-quarter 2026 earnings results. The company met earnings per share expectations, reporting a non-GAAP net loss of $0.14 per share. However, the firm fell short of revenue forecasts, generating only $11,000 in revenue compared to the anticipated $100,000. Alongside these financial updates, Atomera highlighted progress in its GaN-on-silicon RF technology. The company noted a significant reduction in parasitic channel losses in gallium nitride devices built on silicon substrates. This advancement is attributed to Atomera's Mears Silicon Technology, which introduces a thin, oxygen-modified layer near the silicon wafer surface. Testing revealed more than a tenfold reduction in parasitic channel charge compared to reference wafers. These developments reflect Atomera's ongoing efforts to enhance its technology and address challenges in its financial performance.

Atomera Inc Follow Analyze ATOM Included in our AI-picked strategies Review strategies 8.17 ▼-0.64(-7.26%) Closed 8.28 ▲+0.11(+1.35%) After Hours · 22:27:00 1D 1W 1M 6M 1Y 5Y Max Created with Highcharts 11.4.8 14:00 15:00 16:00 17:00 18:00 19:00 8 8.59 Analyze ATOM This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. Spot the trade on ATOM before it happens Most traders know the market. The hard part is the moment — which stock, right now, at what price. Chart analysis handles that. Our Vision AI scans your charts, spots the pattern before it plays out, and hands you the complete setup: entry, exit, done in under 60 seconds. Investors are already reporting a high accuracy rate, even on penny stocks. Flash Sale - Price Goes Up Soon

Risks

  • Atomera remains unprofitable with a market cap of $341 million, indicating potential financial stability concerns for the semiconductor materials sector.
  • The company's revenue significantly missed forecasts, highlighting execution risks in scaling its business within the broader tech market.
  • Stock volatility is evident, with a 270% surge over six months, suggesting potential valuation pressures and market sentiment shifts in the biotech and medtech adoption curves.

More from Insider Trading

Alliance Laundry COO Executes $1.92 Million Stock Sale Under Pre-Arranged Plan Jun 17, 2026 Star Equity Holdings CEO Jeffrey Eberwein Acquires Additional Shares Amid Market Activity Jun 17, 2026 Seacoast Banking Director Dennis Hudson Offloads $251K in Shares Amid Mixed Q1 Earnings Jun 17, 2026 Kestra Medical CEO Executes Pre-Arranged Sale of $312,142 in Stock Jun 17, 2026 United Therapeutics CEO Executes Pre-Arranged Stock Sales Under 10b5-1 Plan Jun 17, 2026